全球马药和补充剂市场规模（按类型、分销管道、区域覆盖范围和预测）

马药和补充剂的市场规模和预测

2024 年马药和补充剂市场规模为 10.8548 亿美元，预计到 2031 年将达到 14.3934 亿美元，2024 年至 2031 年的复合年增长率为 3.59%。由于人们对马药物和补充剂产品的认识不断提高，以及对马草药消化剂、饲料和能量补充剂的需求不断增加，全球马药物和补充剂市场正在强劲增长。全球马药和补充剂市场报告提供了对市场的整体评估。它对关键细分市场、趋势、市场推动因素、阻碍因素、竞争格局以及在市场中发挥关键作用的因素进行了全面分析。

全球马药和补充剂市场定义

马药和补充剂是专门用于治疗疾病或改善营养的药物和补充剂。这些药物和营养补充剂包括维生素、蛋白质、电解质、能量补充剂等。这些医疗设备主要用于驴子、马和斑马，以治癒伤口并提供能量以保持身体健康和强壮。

马药和补充剂是用于改善营养状况和治疗疾病的药物和补充剂。这些药物和营养补充剂含有蛋白质、维生素、能量补充剂和电解质。马药和补充剂为马、驴和斑马提供能量来治癒受伤并保持强壮和健康。各国政府和许多动物卫生机构已向一些马匹饲养员和驯马师提出了关于马匹生长和健康所需的优质、健康营养和补充剂的担忧。此外，它还提供资讯并提高人们对预防各种疾病和治疗某些疾病的必要性的认识。

动物营养补充品（营养保健品）是含有一种或多种营养成分的口服产品，旨在补充饮食。这些成分包括维生素、矿物质、草药等植物、胺基酸（蛋白质的组成部分）、酵素、器官组织、腺体、代谢物、萃取物、浓缩物和其他物质。补充剂有多种剂型，包括丸剂、颗粒剂、粉末、糊剂、液体、注射剂（静脉或肌肉注射）和片剂。

马药和补充剂的全球市场概览

全球马药和补充剂市场是由人们对马药和补充剂的认识不断提高所推动的。随着马匹饲养员和驯马师越来越多地选择有机产品，对马匹的草药消化助剂、饲料和能量补充剂的需求正在增加。此举旨在推动预测期内药品和补充剂市场的成长。

此外，由于马饲养者决定采用有机食品，人们对马药和补充剂、草本饲料的认识不断提高，以及对消化和能量补充剂的需求增加，也推动了需求的成长。此外，赛马和马术运动产业正在推动对马药品的需求，因为马的健康对于这些产业的发展至关重要。在某些赛事中，健康的马匹会为与赛马相关的博彩业带来动力。因此，许多驯马师和饲养员使用优质药物来控制和治疗疾病，以保持他们的马匹适合比赛。严重依赖马匹健康的赛马和马术运动产业正在推动对马药品的需求。这就是为什么大多数驯马师和饲养员使用高品质的药物来预防疾病和治疗疾病，以便他们的马匹能够参加比赛。

然而，对药品和营养补充剂的严格监管是市场的主要障碍。其他投注和赌博途径的可用性正在对已开发国家的马匹相关行业产生影响。此举旨在减缓全球马药品和营养补充剂市场的成长。

赛马运动在某些地区的发展预计将为全球马匹药品和营养保健品市场的主要参与者提供扩张机会。此外，马匹育种的下降导致马匹数量下降，预计在预测期内将继续成为市场的主要课题。

目录

第1章：全球马药和补充剂市场：简介

• 市场概况
• 调查范围
• 先决条件

第 2 章执行摘要

第3章 验证市场研究研究方法

• 数据挖掘
• 验证
• 一次资料
• 数据源列表

第4章全球马药和补充剂市场展望

• 概述
• 市场动态
  • 促进因素
  • 阻碍因素
  • 机会
• 波特的五力模型
• 价值链分析

第5章全球马药和补充剂市场：按产品类型

• 概述
• 药品
• 补充

第6章全球马药和补充剂市场：按分销管道

• 概述
• 动物医院
• 药店
• 其他

第7章全球马药和补充剂市场：按地区

• 概述
• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 亚太其他地区
• 世界其他地区
  • 拉丁美洲
  • 中东

第8章全球马药品和补充品市场：竞争格局

• 概述
• 各公司市场排名
• 主要发展策略

第9章 公司简介

• Zoetis
• Boehringer Ingelheim
• Merck & Co
• Elanco
• Bayer
• Ceva Sante Animale
• Virbac
• Affymetrix
• Celltrion
• Vetoquinol

第10章 主要进展

• 产品发布/开发
• 併购
• 业务拓展
• 伙伴关係和联盟

第11章附录

• 相关研究

Equine Pharmaceuticals And Supplements Market Size And Forecast

Equine Pharmaceuticals and Supplements Market size was valued at USD 1085.48 Million in 2024 and is projected to reach USD 1439.34 Million by 2031, at a CAGR of 3.59% from 2024 to 2031. The global equine pharmaceuticals and supplements market has witnessed strong growth owing to the increasing awareness about equine pharmaceuticals and supplements products and increasing demand for herbal digestive, feed, and energy supplements for horses. The Global Equine Pharmaceuticals and Supplements Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Equine Pharmaceuticals and Supplements Market Definition

Equine pharmaceuticals and supplements are medicines or supplements explicitly used to treat disease or improve nutrition. These medicines and dietary supplements include vitamins, proteins, electrolytes and energy supplements. These medical devices are primarily used on donkeys, horses and zebras to heal injuries and provide these animals with energy to keep them healthy and strong.

Equine pharmaceuticals and supplements are medicines or supplements explicitly used to improve nutrition and cure disease. These medicines and dietary supplements contain proteins, vitamins, energy supplements and electrolytes. Equine medication and supplements give horses, donkeys and zebras the energy to heal injuries and stay strong and healthy. Governments and many animal health agencies have raised concerns among several horse industry horse breeders and trainers about the need for good, healthy nutrition and nutritional supplements for the growth and health of horses. In addition, it provides information and raises awareness of the need to prevent various diseases and treat some.

Also, veterinary nutritional supplements (nutraceuticals) are oral products that contain one or more dietary ingredients intended to supplement the diet. These ingredients include vitamins, minerals, herbs or other botanicals, amino acids (the building blocks of proteins), and substances such as enzymes, organ tissue, glands, metabolites, extracts, or concentrates. Supplements are available in many formulations, including pellets, granules, powders, pastes, liquids, injections (intravenous or intramuscular), and pills.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Equine Pharmaceuticals and Supplements Market Overview

The global equine pharmaceuticals and supplements market is driven by increasing awareness of equine pharmaceuticals and supplements. With horse breeders and trainers choosing organic products, demand for herbal digestives, feeds and energy supplements for horses is increasing. It is designed to drive the growth of the pharmaceutical and supplements market during the forecast period.

Moreover, increasing awareness of equine medicines and supplements, increasing demand for herbal feed, and digestive and energy supplements as horse breeders decide to go organic are driving demand for the product. Further, the horseracing and equestrian sports industries are driving the need for equine medicines, as horses' health is essential to the growth of these industries. Healthy horses in specific disciplines give impetus to the betting and gambling industry associated with horse racing. Therefore, most horse trainers and breeders use superior medicines to limit and cure ailments to keep horses in good shape for racing. The horse racing and equestrian sports industry, which relies heavily on horse health, drives demand for equine medicines. As a result, most horse trainers and breeders use high-quality pharmaceuticals to prevent disease and cure disorders to ensure their horses are ready to race.

However, stringent regulations on pharmaceuticals and dietary supplements are significantly hampering the market. The availability of alternative betting and gambling vehicles impacts the horse-related industry in developed countries. It is intended to slow down the growth of the global equine medicines and nutritional supplements market.

The development of horse racing in specific geographic regions is expected to provide expansion opportunities for key players in the global equine medicines and nutritional supplements market. Furthermore, declining horse breeding will lead to declining horse populations and is expected to remain a significant challenge for the market during the forecast period.

Global Equine Pharmaceuticals and Supplements Market Segmentation Analysis

The Global Equine Pharmaceuticals and Supplements Market is segmented based on Type, Distribution Channel, and Geography.

Equine Pharmaceuticals and Supplements Market, By Type

• Pharmaceuticals
• Supplements

Based on Type, the market is bifurcated into Pharmaceuticals and Supplements. The Pharmaceuticals segment is estimated to witness the highest CAGR for the forecast period. The factors attributed to the segment's growth are associated with the increasing demand for pharmaceuticals to limit illnesses and heal diseases so that the horses are in good shape for the races, thus promulgating segment growth.

Equine Pharmaceuticals and Supplements Market, By Distribution Channel

• Veterinary Hospitals
• Drugstores
• Others

Based on Distribution Channel, the market is bifurcated into Veterinary Hospitals, Drugstores, and Others. The Drugstore's segment is estimated to witness the highest CAGR for the forecast period. The factors attributed to the segment's growth are associated with the increasing owner preference for treating horses in hospitals and improved availability of veterinary supplements. Also, the massive availability of equine pharmaceuticals at drug stores. These medications are used to treat horses, donkeys and zebras.

Equine Pharmaceuticals and Supplements Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• The Asia-Pacific region is anticipated to become the fastest-growing equine pharmaceuticals and supplements market due to the development of horseracing and other horse-related activities in countries such as China, Australia, and New Zealand. With important horse races such as the Dubai World Cup, growth in the Middle East for equine breeding and other related equine sporting and non-sporting sectors is noteworthy and expected to boost the development of the Middle East equine medicines and supplements market.

Key Players

• The "Global Equine Pharmaceuticals and Supplements Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Zoetis, Boehringer Ingelheim, Merck & Co, Elanco, Bayer, Ceva Sante Animale, Virbac, Vetoquinol, Affymetrix, Celltrion.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Pharmaceuticals
• 5.3 Supplements

6 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL

• 6.1 Overview
• 6.2 Veterinary Hospitals
• 6.3 Drugstores
• 6.4 Others

7 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East

8 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Zoetis
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Boehringer Ingelheim
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Merck & Co
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Elanco
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Bayer
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Ceva Sante Animale
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Virbac
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Affymetrix
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Celltrion
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Vetoquinol
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research